RXL:ARCA-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 48.08

Change

-0.27 (-0.56)%

Market Cap

USD 0.07B

Volume

4.40K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health CareSM Index. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index measures the performance of the healthcare sector of the U.S. equity market. Component companies include, among others, health care providers, biotechnology companies, medical supplies, advanced medical devices and pharmaceuticals. The fund is non-diversified.

Inception Date: 30/01/2007

Primary Benchmark: DJ US Health Care TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.06%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

N/A

USD 8.29B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 6.07B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

N/A

USD 5.57B
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 4.37B
UPRO ProShares UltraPro S&P500 0.92 %

N/A

USD 3.08B
TECL Direxion Daily Technology Bull.. 1.17 %

N/A

USD 2.48B
YINN Direxion Daily FTSE China Bull.. 1.02 %

N/A

USD 1.91B
USD ProShares Ultra Semiconductors 0.95 %

N/A

USD 0.82B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.66B
UDOW ProShares UltraPro Dow30 0.95 %

N/A

USD 0.59B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 9.26B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.23B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.30% 75% C 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.30% 75% C 88% B+
Trailing 12 Months  
Capital Gain -9.50% 48% F 25% F
Dividend Return 1.13% 73% C 24% F
Total Return -8.36% 45% F 23% F
Trailing 5 Years  
Capital Gain 130.21% 45% F 78% C+
Dividend Return 6.04% 34% F 11% F
Total Return 136.26% 42% F 74% C
Average Annual (5 Year Horizon)  
Capital Gain 9.42% 26% F 65% D
Dividend Return 9.79% 26% F 60% D-
Total Return 0.37% 23% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 29.71% 97% N/A 34% F
Risk Adjusted Return 32.94% 53% F 47% F
Market Capitalization 0.07B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.